EUCTR2009-016815-39-SE进行中（未招募）1 期
Is Intralymphatic Allergen Immunotherapy effective and safe: A human randomized clinical trial - Intralympatic ASIT
Allergy Unit Department of Oto-rhino-Laryngology Lund/Malmö University Hospital0 个研究点目标入组 100 人开始时间: 2009年11月6日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Age 18-65,
- •- Seasonal allergic symptoms for grass verified by skin prick test,
- •- Accepted informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Pregnancy or nursing,
- •- Autoimmune or collagen disease (known),
- •- Cardiovascular disease,
- •- Perennial pulmonary disease,
- •- Hepatic disease,
- •- Renal disease,
- •- Any medication with a possible side-effect of interfering with the immune response,
- •- Previous immuno- or chemotherapy,
- •- Chronic diseases,
- •- Upper airway disease (non-allergic sinusitis, nasal polyps, chronic obstructive and restrictive lung disease),
- •- Disease or conditions rendering the treatment of anaphylactic reactions difficult (symptomatic coronary heart diseases, severe arterial hypertension and treatment with ß-blockers),
- •- Major metabolic disease,
- •- Known or suspected allergy to the study product,
- •- Alcohol or drug abuse,
- •- Mental incapability of coping with the study,
- •- Withdrawal of informed consent.
研究者
相似试验
已完成
2 期
The Safety and Efficacy of Intralymphatic Immunotherapy in Pollen Allergic Adolescents and Young Adults With AsthmaAsthmaAllergyRhinitisNCT03394508Karolinska Institutet30
已完成
2 期
Is Intralymphatic Allergen Immunotherapy Effective and Safe?Allergic Rhinitis Due to Grass PollenNCT04210193Lars Olaf Cardell15
已完成
2 期
Intralymphatic Immunotherapy in Increasing Doses, SubstudyRhinitis, Allergic, SeasonalNCT02975479Karolinska Institutet40
已完成
2 期
Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous ImmunotherapyRhinitis, AllergicNCT02679105Karolinska Institutet38
进行中（未招募）
1 期
Effect of low dose intralymphatic immunotherapyMedDRA version: 21.1Level: PTClassification code 10039085Term: Rhinitis allergicSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 20.0Level: PTClassification code 10010744Term: Conjunctivitis allergicSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAllergic rhinitisEUCTR2020-005823-35-DKAarhus Universitet40